US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Verrica Pharmaceuticals Inc.

9.10

+2.3935.62%

Post-market: 8.77-0.3300-3.63%16:59 EST

Volume:2.62M

Turnover:22.84M

Market Cap:86.36M

PE:-3.08

High:9.82

Open:7.30

Low:6.92

Close:6.71

52wk High:13.20

52wk Low:3.28

Shares:9.49M

Float Shares:1.94M

Volume Ratio:11.19

T/O Rate:135.44%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.9552

EPS(LYR):-14.7812

ROE:-1546.58%

ROA:-26.28%

PB:-5.07

PE(LYR):-0.62

Loading ...

Overview Company News Filings

BUZZ-Verrica Pharma climbs after EU nod clears path for skin drug filing

Verrica Pharmaceuticals Inc - Plans Regulatory Submission for Ycanth by Q4 2026

THOMSON REUTERS

Verrica Pharmaceuticals Receives Positive Feedback From the European Medicines Agency (Ema) Supporting a Clear Regulatory Path Forward to File for Approval of Ycanth® in the European Union

THOMSON REUTERS

Verrica Pharmaceuticals Announces Positive Phase 2 Trial Results for VP-315 in Basal Cell Carcinoma at SITC 2025 Annual Meeting

Verrica Says Development Partner Receives Japanese Approval For Ycanth; Shares Rise Pre-Bell

MT Newswires Live

Verrica Pharmaceuticals Inc - Approval Triggers $10 Mln Milestone Payment to Verrica

THOMSON REUTERS

Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for Ycanth® (to-208) in Japan for the Treatment of Molluscum Contagiosum

THOMSON REUTERS

Verrica Pharmaceuticals Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference

Lytix Biopharma AS Announces Milestone-Rich Second Half of 2025 with Advancements in Ruxotemitide Clinical Trials and Strategic Preparations for Future Commercialization

U.S. RESEARCH ROUNDUP-Apollo, Blackstone, Nvidia

Verrica Pharmaceuticals Inc : TD Cowen Raises Target Price to $20 From $5

THOMSON REUTERS

Verrica Pharmaceuticals Q2 Adj. EPS $0.25 Beats $(0.07) Estimate, Sales $12.702M Beat $4.367M Estimate

Verrica Pharmaceuticals Inc expected to post a loss of 70 cents a share - Earnings Preview

BRIEF-Verrica Pharmaceuticals To Report Second Quarter 2025 Financial Results And Provide A Corporate Update On August 12, 2025

Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 12, 2025

THOMSON REUTERS

Verrica Pharmaceuticals Announces 1-for-10 Reverse Stock Split Effective July 24, 2025

Verrica Pharmaceuticals Inc. Reports 32.8% Increase in YCANTH® Sales for Q2 2025 and Receives $8M Milestone Payment from Torii Pharmaceutical

BRIEF-Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025

Verrica Pharmaceuticals Announces Launch of Global Phase 3 Trial for YCANTH® to Treat Common Warts, Anticipates Dosing First Patient in Late 2025

Verrica Pharmaceuticals Announces Sixth Amendment to Credit Agreement with Lenders

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VRCA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VRCA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRCA\",,,,,undefined,":{"symbol":"VRCA","market":"US","secType":"STK","nameCN":"Verrica Pharmaceuticals Inc.","latestPrice":9.1,"timestamp":1764352800000,"preClose":6.71,"halted":0,"volume":2621454,"hourTrading":{"tag":"盘后","latestPrice":8.77,"preClose":9.1,"latestTime":"16:59 EST","volume":58714,"amount":520907.7909,"timestamp":1764367140395},"delay":0,"floatShares":1935557,"shares":9490000,"eps":-2.955175,"marketStatus":"Market Closed","change":2.39,"latestTime":"11-28 13:00:00 EST","open":7.3,"high":9.8212,"low":6.92,"amount":22838967.084912,"amplitude":0.43237,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.955175,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1764579600000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1529035200000,"exchange":"NASDAQ","adjPreClose":6.71,"preHourTrading":{"tag":"盘前","latestPrice":7.46,"preClose":6.71,"latestTime":"09:29 EST","volume":17303,"amount":129628.66016099999,"timestamp":1764340163757},"postHourTrading":{"tag":"盘后","latestPrice":8.77,"preClose":9.1,"latestTime":"16:59 EST","volume":58714,"amount":520907.7909,"timestamp":1764367140395},"volumeRatio":11.185820835115416,"impliedVol":0.3196,"impliedVolPercentile":0.4136},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRCA\",,,,,undefined,":{"symbol":"VRCA","floatShares":1935557,"roa":"-26.28%","roe":"-1546.58%","lyrEps":-14.781242,"volumeRatio":11.185820835115416,"shares":9490000,"dividePrice":0,"high":9.8212,"amplitude":0.43237,"preClose":6.71,"low":6.92,"week52Low":3.28,"pbRate":"-5.07","psRate":"2.80","week52High":13.2,"institutionHeld":0,"latestPrice":9.1,"eps":-2.955175,"divideRate":0,"volume":2621454,"delay":0,"ttmEps":-2.955175,"open":7.3,"prevYearClose":7,"prevWeekClose":4.21,"prevMonthClose":3.61,"prevQuarterClose":4.31,"fiveDayClose":4.02,"twentyDayClose":3.53,"sixtyDayClose":5.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRCA\",params:#limit:5,,,undefined,":[{"date":"2025-11-14","symbol":"VRCA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763154000000,"name":null,"time":"Post Market","dateTimestamp":1763096400000,"actualEps":null},{"market":"US","date":"2025-08-12","symbol":"VRCA","fiscalQuarterEnding":"2025/06","expectedEps":-0.7,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":0.02},{"market":"US","date":"2025-07-25","symbol":"VRCA","defaultRemindTime":1753450200000,"type":"split","dateTimestamp":1753416000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-05-13","symbol":"VRCA","fiscalQuarterEnding":"2025/03","expectedEps":-0.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.1},{"market":"US","date":"2025-03-11","symbol":"VRCA","fiscalQuarterEnding":"2024/12","expectedEps":-0.25,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741665600000,"reportTimeType":"pre","actualEps":-0.24}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRCA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRCA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1667,"buy":0.3333,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":6,"updateTime":1762837200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRCA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRCA","date":"2025-11-28","current":-3.079344,"percent":0.633849,"low":-13.801958,"twenty":-8.963555,"median":-4.80244,"eighty":-0.95209,"high":-0.377883,"avg":-5.209154,"sd":3.590454,"marketCap":86359318},"quantilePoints":[{"date":"2020-12-04","current":-6.869041,"twenty":-21.304692,"median":-12.746647,"eighty":-8.299368,"marketCap":256586176},{"date":"2020-12-11","current":-7.478392,"twenty":-21.265718,"median":-12.6844,"eighty":-8.174178,"marketCap":279347853},{"date":"2020-12-18","current":-7.31913,"twenty":-21.248002,"median":-12.583482,"eighty":-8.013319,"marketCap":273398778},{"date":"2020-12-24","current":-8.309324,"twenty":-21.226744,"median":-12.530874,"eighty":-7.980607,"marketCap":310386504},{"date":"2020-12-31","current":-7.970027,"twenty":-21.205485,"median":-12.463724,"eighty":-7.977587,"marketCap":297712388},{"date":"2021-01-08","current":-8.385493,"twenty":-21.170054,"median":-12.45024,"eighty":-8.009658,"marketCap":313231713},{"date":"2021-01-15","current":-7.540712,"twenty":-20.999985,"median":-12.438385,"eighty":-7.947222,"marketCap":281675752},{"date":"2021-01-22","current":-8.752488,"twenty":-20.886606,"median":-12.400157,"eighty":-7.943413,"marketCap":326940450},{"date":"2021-01-29","current":-8.136213,"twenty":-20.815743,"median":-12.201819,"eighty":-7.96246,"marketCap":303920118},{"date":"2021-02-05","current":-9.666514,"twenty":-20.727166,"median":-12.147573,"eighty":-7.970027,"marketCap":361082966},{"date":"2021-02-12","current":-9.444932,"twenty":-20.691735,"median":-12.093054,"eighty":-8.007828,"marketCap":352805992},{"date":"2021-02-19","current":-10.317411,"twenty":-20.606701,"median":-12.008831,"eighty":-8.010825,"marketCap":385396575},{"date":"2021-02-26","current":-9.493403,"twenty":-20.571269,"median":-11.965898,"eighty":-8.015899,"marketCap":354616580},{"date":"2021-03-05","current":-8.28783,"twenty":-20.468519,"median":-11.952231,"eighty":-8.046266,"marketCap":353840614},{"date":"2021-03-12","current":-10.256795,"twenty":-20.387027,"median":-11.889494,"eighty":-8.053587,"marketCap":437903626},{"date":"2021-03-19","current":-9.433007,"twenty":-20.174441,"median":-11.801009,"eighty":-8.06169,"marketCap":402732818},{"date":"2021-03-26","current":-8.520381,"twenty":-20.068148,"median":-11.67409,"eighty":-8.071858,"marketCap":363769158},{"date":"2021-04-01","current":-9.865366,"twenty":-19.841389,"median":-11.59076,"eighty":-8.078665,"marketCap":421191933},{"date":"2021-04-09","current":-8.855019,"twenty":-19.689036,"median":-11.524855,"eighty":-8.093693,"marketCap":378056165},{"date":"2021-04-16","current":-8.166438,"twenty":-19.660691,"median":-11.480525,"eighty":-8.122364,"marketCap":348657902},{"date":"2021-04-23","current":-8.711984,"twenty":-19.646519,"median":-11.455341,"eighty":-8.140368,"marketCap":371949441},{"date":"2021-04-30","current":-8.499497,"twenty":-19.62526,"median":-11.384529,"eighty":-8.155602,"marketCap":362877504},{"date":"2021-05-07","current":-9.323537,"twenty":-19.547312,"median":-11.276316,"eighty":-8.093693,"marketCap":315210124},{"date":"2021-05-14","current":-9.485685,"twenty":-19.504794,"median":-11.133771,"eighty":-8.122364,"marketCap":320692039},{"date":"2021-05-21","current":-9.201925,"twenty":-19.345355,"median":-11.069937,"eighty":-8.140368,"marketCap":311098687},{"date":"2021-05-28","current":-9.128958,"twenty":-19.239062,"median":-11.021311,"eighty":-8.155602,"marketCap":308631825},{"date":"2021-06-04","current":-7.920952,"twenty":-19.210717,"median":-11.012373,"eighty":-8.11544,"marketCap":267791557},{"date":"2021-06-11","current":-8.504687,"twenty":-19.132769,"median":-10.940895,"eighty":-8.138983,"marketCap":287526452},{"date":"2021-06-18","current":-9.380289,"twenty":-18.874122,"median":-10.892695,"eighty":-8.151447,"marketCap":317128794},{"date":"2021-06-25","current":-9.266785,"twenty":-18.558786,"median":-10.868389,"eighty":-8.164922,"marketCap":313291453},{"date":"2021-07-02","current":-9.364074,"twenty":-18.548156,"median":-10.785238,"eighty":-8.166438,"marketCap":316580602},{"date":"2021-07-09","current":-8.407398,"twenty":-18.54107,"median":-10.67511,"eighty":-8.175627,"marketCap":284237303},{"date":"2021-07-16","current":-8.334431,"twenty":-18.502096,"median":-10.653174,"eighty":-8.216537,"marketCap":281770441},{"date":"2021-07-23","current":-8.569546,"twenty":-18.434776,"median":-10.578686,"eighty":-8.236089,"marketCap":289719218},{"date":"2021-07-30","current":-8.674943,"twenty":-18.332027,"median":-10.561182,"eighty":-8.249241,"marketCap":293282463},{"date":"2021-08-06","current":-8.593868,"twenty":-18.317854,"median":-10.529864,"eighty":-8.255232,"marketCap":290541505},{"date":"2021-08-13","current":-8.169074,"twenty":-18.303682,"median":-10.515423,"eighty":-8.236089,"marketCap":295508092},{"date":"2021-08-20","current":-7.492121,"twenty":-18.229276,"median":-10.48706,"eighty":-8.166438,"marketCap":271019992},{"date":"2021-08-27","current":-8.420079,"twenty":-18.158414,"median":-10.428202,"eighty":-8.164416,"marketCap":304587950},{"date":"2021-09-03","current":-10.618275,"twenty":-18.147785,"median":-10.414533,"eighty":-8.166438,"marketCap":384105491},{"date":"2021-09-10","current":-9.165488,"twenty":-18.105268,"median":-10.360513,"eighty":-8.166438,"marketCap":331552376},{"date":"2021-09-17","current":-9.256763,"twenty":-18.087552,"median":-10.317411,"eighty":-8.169074,"marketCap":334854142},{"date":"2021-09-24","current":-8.754753,"twenty":-17.786388,"median":-10.276924,"eighty":-8.212382,"marketCap":316694427},{"date":"2021-10-01","current":-9.515374,"twenty":-17.715526,"median":-10.222565,"eighty":-8.233156,"marketCap":344209147},{"date":"2021-10-08","current":-9.439312,"twenty":-17.573802,"median":-10.190534,"eighty":-8.247819,"marketCap":341457675},{"date":"2021-10-15","current":-10.161902,"twenty":-17.520656,"median":-10.161902,"eighty":-8.254927,"marketCap":367596659},{"date":"2021-10-22","current":-9.713136,"twenty":-17.006905,"median":-10.125651,"eighty":-8.256454,"marketCap":351362974},{"date":"2021-10-29","current":-9.576224,"twenty":-16.210213,"median":-10.103591,"eighty":-8.274702,"marketCap":346410324},{"date":"2021-11-05","current":-10.017384,"twenty":-16.174276,"median":-10.087097,"eighty":-8.28783,"marketCap":362368862},{"date":"2021-11-12","current":-8.809355,"twenty":-16.065695,"median":-10.077527,"eighty":-8.288551,"marketCap":339309923},{"date":"2021-11-19","current":-8.173481,"twenty":-16.06081,"median":-10.059534,"eighty":-8.28783,"marketCap":314817966},{"date":"2021-11-26","current":-7.473305,"twenty":-15.941288,"median":-10.041766,"eighty":-8.253505,"marketCap":287849294},{"date":"2021-12-03","current":-6.615947,"twenty":-15.702243,"median":-10.020775,"eighty":-8.1726,"marketCap":254826430},{"date":"2021-12-10","current":-6.987469,"twenty":-15.573376,"median":-10.010115,"eighty":-8.159756,"marketCap":269136338},{"date":"2021-12-17","current":-6.501633,"twenty":-15.554232,"median":-10.002172,"eighty":-8.101396,"marketCap":250423382},{"date":"2021-12-23","current":-6.737406,"twenty":-15.545879,"median":-9.957163,"eighty":-8.078665,"marketCap":259504669},{"date":"2021-12-31","current":-6.5445,"twenty":-15.404401,"median":-9.905662,"eighty":-8.050103,"marketCap":252074525},{"date":"2022-01-07","current":-6.480199,"twenty":-15.306325,"median":-9.880472,"eighty":-8.005508,"marketCap":249597810},{"date":"2022-01-14","current":-5.94435,"twenty":-15.155456,"median":-9.873556,"eighty":-7.967,"marketCap":228958520},{"date":"2022-01-21","current":-5.537105,"twenty":-15.045894,"median":-9.865313,"eighty":-7.935851,"marketCap":213272660},{"date":"2022-01-28","current":-5.43708,"twenty":-15.02557,"median":-9.832701,"eighty":-7.874921,"marketCap":209419993},{"date":"2022-02-04","current":-5.587117,"twenty":-15.00857,"median":-9.792473,"eighty":-7.845703,"marketCap":215198994},{"date":"2022-02-11","current":-5.887193,"twenty":-14.96848,"median":-9.783278,"eighty":-7.809671,"marketCap":226756996},{"date":"2022-02-18","current":-5.644274,"twenty":-14.936962,"median":-9.765677,"eighty":-7.717235,"marketCap":217400518},{"date":"2022-02-25","current":-5.758589,"twenty":-14.896984,"median":-9.762103,"eighty":-7.561149,"marketCap":221803567},{"date":"2022-03-04","current":-6.38555,"twenty":-14.755152,"median":-9.755823,"eighty":-7.515219,"marketCap":224005091},{"date":"2022-03-11","current":-6.181589,"twenty":-14.745783,"median":-9.737752,"eighty":-7.481244,"marketCap":216850137},{"date":"2022-03-18","current":-6.754249,"twenty":-14.723661,"median":-9.713136,"eighty":-7.424792,"marketCap":236939046},{"date":"2022-03-25","current":-6.542443,"twenty":-14.660984,"median":-9.687818,"eighty":-7.341298,"marketCap":229508902},{"date":"2022-04-01","current":-6.652268,"twenty":-14.645285,"median":-9.674618,"eighty":-7.270396,"marketCap":233361569},{"date":"2022-04-08","current":-6.887608,"twenty":-14.640589,"median":-9.665964,"eighty":-7.202806,"marketCap":241617285},{"date":"2022-04-14","current":-6.212967,"twenty":-14.637019,"median":-9.648308,"eighty":-7.123217,"marketCap":217950899},{"date":"2022-04-22","current":-5.726599,"twenty":-14.637019,"median":-9.621861,"eighty":-7.033623,"marketCap":200889086},{"date":"2022-04-29","current":-5.153939,"twenty":-14.480326,"median":-9.575546,"eighty":-7.002293,"marketCap":180800178},{"date":"2022-05-06","current":-4.816619,"twenty":-14.461891,"median":-9.561011,"eighty":-6.987469,"marketCap":168966985},{"date":"2022-05-13","current":-3.655086,"twenty":-14.438154,"median":-9.538384,"eighty":-6.96313,"marketCap":155757839},{"date":"2022-05-20","current":-3.835903,"twenty":-14.425022,"median":-9.508724,"eighty":-6.931361,"marketCap":163463174},{"date":"2022-05-27","current":-1.29155,"twenty":-14.39737,"median":-9.496783,"eighty":-6.895453,"marketCap":55038106},{"date":"2022-06-03","current":-1.465909,"twenty":-14.373536,"median":-9.485685,"eighty":-6.879432,"marketCap":62468250},{"date":"2022-06-10","current":-1.356127,"twenty":-14.325047,"median":-9.469488,"eighty":-6.861307,"marketCap":57790011},{"date":"2022-06-17","current":-1.452994,"twenty":-14.292293,"median":-9.460652,"eighty":-6.808853,"marketCap":61917869},{"date":"2022-06-24","current":-1.362585,"twenty":-14.264642,"median":-9.453534,"eighty":-6.788739,"marketCap":58065201},{"date":"2022-07-01","current":-2.012398,"twenty":-14.233303,"median":-9.439312,"eighty":-6.769114,"marketCap":85756345},{"date":"2022-07-08","current":-3.199435,"twenty":-14.196357,"median":-9.43704,"eighty":-6.737867,"marketCap":136340732},{"date":"2022-07-15","current":-3.095506,"twenty":-14.146545,"median":-9.427646,"eighty":-6.720845,"marketCap":131911910},{"date":"2022-07-22","current":-2.98943,"twenty":-14.126383,"median":-9.420826,"eighty":-6.650804,"marketCap":127391564},{"date":"2022-07-29","current":-3.037646,"twenty":-14.11343,"median":-9.393106,"eighty":-6.6457,"marketCap":129446266},{"date":"2022-08-05","current":-3.259443,"twenty":-14.098659,"median":-9.386069,"eighty":-6.629464,"marketCap":138897899},{"date":"2022-08-12","current":-4.048576,"twenty":-14.089457,"median":-9.372181,"eighty":-6.615947,"marketCap":166019974},{"date":"2022-08-19","current":-3.407218,"twenty":-14.080212,"median":-9.36325,"eighty":-6.60378,"marketCap":139719780},{"date":"2022-08-26","current":-3.707855,"twenty":-14.074766,"median":-9.323537,"eighty":-6.587248,"marketCap":152047996},{"date":"2022-09-02","current":-3.948364,"twenty":-14.072368,"median":-9.298233,"eighty":-6.568162,"marketCap":161910568},{"date":"2022-09-09","current":-4.108704,"twenty":-14.068127,"median":-9.293402,"eighty":-6.548507,"marketCap":168485617},{"date":"2022-09-16","current":-3.607642,"twenty":-14.065549,"median":-9.287796,"eighty":-6.536167,"marketCap":147938590},{"date":"2022-09-23","current":-2.886114,"twenty":-14.063705,"median":-9.273837,"eighty":-6.523501,"marketCap":118350872},{"date":"2022-09-30","current":-2.926199,"twenty":-14.054478,"median":-9.269303,"eighty":-6.510959,"marketCap":119994634},{"date":"2022-10-07","current":-2.435159,"twenty":-14.038958,"median":-9.256763,"eighty":-6.47805,"marketCap":99858548},{"date":"2022-10-14","current":-2.735795,"twenty":-14.005422,"median":-9.237861,"eighty":-6.42674,"marketCap":112186764},{"date":"2022-10-21","current":-2.405095,"twenty":-13.997341,"median":-9.233944,"eighty":-6.407981,"marketCap":98625727},{"date":"2022-10-28","current":-2.425137,"twenty":-13.971532,"median":-9.225586,"eighty":-6.34789,"marketCap":99447608},{"date":"2022-11-04","current":-2.294861,"twenty":-13.919916,"median":-9.203519,"eighty":-6.323973,"marketCap":94105381},{"date":"2022-11-11","current":-3.45193,"twenty":-13.888612,"median":-9.197563,"eighty":-6.255329,"marketCap":96981965},{"date":"2022-11-18","current":-3.539691,"twenty":-13.879534,"median":-9.165488,"eighty":-6.211558,"marketCap":99447608},{"date":"2022-11-25","current":-3.788347,"twenty":-13.872169,"median":-9.151804,"eighty":-6.15021,"marketCap":106433597},{"date":"2022-12-02","current":-4.914612,"twenty":-13.871986,"median":-9.14739,"eighty":-6.10155,"marketCap":138076018},{"date":"2022-12-09","current":-4.519688,"twenty":-13.837527,"median":-9.128958,"eighty":-6.040385,"marketCap":126980623},{"date":"2022-12-16","current":-4.344166,"twenty":-13.816682,"median":-9.113473,"eighty":-6.010411,"marketCap":122049337},{"date":"2022-12-23","current":-3.671332,"twenty":-13.816682,"median":-9.097752,"eighty":-5.987218,"marketCap":103146073},{"date":"2022-12-30","current":-4.022376,"twenty":-13.809189,"median":-9.072206,"eighty":-5.975782,"marketCap":113008645},{"date":"2023-01-06","current":-5.675206,"twenty":-13.790814,"median":-9.048839,"eighty":-5.963696,"marketCap":159444925},{"date":"2023-01-13","current":-7.094008,"twenty":-13.774283,"median":-9.048276,"eighty":-5.966499,"marketCap":199306157},{"date":"2023-01-20","current":-6.070131,"twenty":-13.766909,"median":-9.029872,"eighty":-5.967544,"marketCap":170540319},{"date":"2023-01-27","current":-6.889233,"twenty":-13.761379,"median":-9.007347,"eighty":-5.972089,"marketCap":193552989},{"date":"2023-02-03","current":-7.664454,"twenty":-13.754146,"median":-8.998696,"eighty":-5.979662,"marketCap":215332837},{"date":"2023-02-10","current":-10.385043,"twenty":-13.739615,"median":-8.99924,"eighty":-5.983253,"marketCap":291767776},{"date":"2023-02-17","current":-11.584442,"twenty":-13.733946,"median":-9.009597,"eighty":-5.985324,"marketCap":325464899},{"date":"2023-02-24","current":-11.974593,"twenty":-13.731884,"median":-9.029872,"eighty":-5.987218,"marketCap":336426186},{"date":"2023-03-03","current":-10.73841,"twenty":-13.720823,"median":-9.048668,"eighty":-5.990491,"marketCap":301695622},{"date":"2023-03-10","current":-11.21205,"twenty":-13.704314,"median":-9.057958,"eighty":-6.004597,"marketCap":274549467},{"date":"2023-03-17","current":-11.998261,"twenty":-13.69687,"median":-9.078186,"eighty":-6.009004,"marketCap":293801412},{"date":"2023-03-24","current":-11.160775,"twenty":-13.691896,"median":-9.102099,"eighty":-6.013181,"marketCap":273293906},{"date":"2023-03-31","current":-11.109501,"twenty":-13.676811,"median":-9.124348,"eighty":-6.024347,"marketCap":272038344},{"date":"2023-04-06","current":-10.340381,"twenty":-13.670364,"median":-9.142652,"eighty":-6.024696,"marketCap":253204920},{"date":"2023-04-14","current":-10.76767,"twenty":-13.669206,"median":-9.149196,"eighty":-6.03254,"marketCap":263667933},{"date":"2023-04-21","current":-10.528388,"twenty":-13.650772,"median":-9.161388,"eighty":-6.040385,"marketCap":257808646},{"date":"2023-04-28","current":-10.135283,"twenty":-13.633013,"median":-9.181896,"eighty":-6.062388,"marketCap":248182674},{"date":"2023-05-05","current":-10.955677,"twenty":-13.632835,"median":-9.201925,"eighty":-6.062388,"marketCap":268271659},{"date":"2023-05-12","current":-11.756195,"twenty":-13.632337,"median":-9.224245,"eighty":-6.070131,"marketCap":265760536},{"date":"2023-05-19","current":-10.97862,"twenty":-13.62363,"median":-9.232771,"eighty":-6.093505,"marketCap":248182674},{"date":"2023-05-26","current":-10.849024,"twenty":-13.620563,"median":-9.234057,"eighty":-6.10155,"marketCap":245253030},{"date":"2023-06-02","current":-10.552805,"twenty":-13.615653,"median":-9.247013,"eighty":-6.114083,"marketCap":238556702},{"date":"2023-06-09","current":-10.552805,"twenty":-13.614007,"median":-9.264369,"eighty":-6.118509,"marketCap":238556702},{"date":"2023-06-16","current":-11.608085,"twenty":-13.590351,"median":-9.271821,"eighty":-6.127261,"marketCap":262412372},{"date":"2023-06-23","current":-11.348893,"twenty":-13.555269,"median":-9.269303,"eighty":-6.124452,"marketCap":256553084},{"date":"2023-06-30","current":-10.663887,"twenty":-13.492373,"median":-9.266785,"eighty":-6.121642,"marketCap":241067825},{"date":"2023-07-07","current":-10.793483,"twenty":-13.458555,"median":-9.266785,"eighty":-6.121642,"marketCap":243997468},{"date":"2023-07-14","current":-12.792961,"twenty":-13.409279,"median":-9.266785,"eighty":-6.121642,"marketCap":289197686},{"date":"2023-07-21","current":-13.292831,"twenty":-13.327224,"median":-9.266785,"eighty":-6.121642,"marketCap":300497740},{"date":"2023-07-28","current":-9.590093,"twenty":-13.290873,"median":-9.266785,"eighty":-6.121642,"marketCap":216793634},{"date":"2023-08-04","current":-9.849284,"twenty":-13.221364,"median":-9.266785,"eighty":-6.121642,"marketCap":222652921},{"date":"2023-08-11","current":-9.581818,"twenty":-13.103509,"median":-9.264369,"eighty":-6.121642,"marketCap":224482838},{"date":"2023-08-18","current":-8.220663,"twenty":-13.051899,"median":-9.23417,"eighty":-6.121642,"marketCap":192593687},{"date":"2023-08-25","current":-7.808734,"twenty":-12.975777,"median":-9.224924,"eighty":-6.121642,"marketCap":182943023},{"date":"2023-09-01","current":-8.149023,"twenty":-12.885999,"median":-9.197563,"eighty":-6.121642,"marketCap":190915310},{"date":"2023-09-08","current":-7.486355,"twenty":-12.87598,"median":-9.161388,"eighty":-6.121642,"marketCap":175390329},{"date":"2023-09-15","current":-7.540085,"twenty":-12.821585,"median":-9.142652,"eighty":-6.121642,"marketCap":176649111},{"date":"2023-09-22","current":-6.716228,"twenty":-12.731741,"median":-9.099561,"eighty":-6.121642,"marketCap":157347783},{"date":"2023-09-29","current":-6.805777,"twenty":-12.614132,"median":-9.06243,"eighty":-6.121642,"marketCap":159445754},{"date":"2023-10-06","current":-7.056517,"twenty":-12.464757,"median":-9.042033,"eighty":-6.118832,"marketCap":165320071},{"date":"2023-10-13","current":-6.537128,"twenty":-12.44537,"median":-8.99924,"eighty":-6.118832,"marketCap":153151842},{"date":"2023-10-20","current":-6.340119,"twenty":-12.38566,"median":-8.968705,"eighty":-6.118832,"marketCap":148536307},{"date":"2023-10-27","current":-6.286389,"twenty":-12.188778,"median":-8.921666,"eighty":-6.117862,"marketCap":147277525},{"date":"2023-11-03","current":-7.092336,"twenty":-12.124264,"median":-8.88076,"eighty":-6.107816,"marketCap":166159259},{"date":"2023-11-10","current":-2.787856,"twenty":-12.053336,"median":-8.855019,"eighty":-6.079481,"marketCap":134689702},{"date":"2023-11-17","current":-3.021216,"twenty":-11.974282,"median":-8.823841,"eighty":-6.033784,"marketCap":145963998},{"date":"2023-11-24","current":-3.291123,"twenty":-11.946973,"median":-8.809355,"eighty":-6.009356,"marketCap":159004010},{"date":"2023-12-01","current":-3.204056,"twenty":-11.792001,"median":-8.772232,"eighty":-5.983253,"marketCap":154797555},{"date":"2023-12-08","current":-3.491376,"twenty":-11.680352,"median":-8.755058,"eighty":-5.963696,"marketCap":168678857},{"date":"2023-12-15","current":-3.273709,"twenty":-11.5949,"median":-8.746737,"eighty":-5.94435,"marketCap":158162719},{"date":"2023-12-22","current":-5.580978,"twenty":-11.531982,"median":-8.733866,"eighty":-5.919137,"marketCap":269633784},{"date":"2023-12-29","current":-6.347165,"twenty":-11.481358,"median":-8.726015,"eighty":-5.897703,"marketCap":306650591},{"date":"2024-01-05","current":-5.833471,"twenty":-11.456718,"median":-8.705341,"eighty":-5.887193,"marketCap":281832505},{"date":"2024-01-12","current":-5.180471,"twenty":-11.382196,"median":-8.657402,"eighty":-5.847771,"marketCap":250284090},{"date":"2024-01-19","current":-5.015044,"twenty":-11.319267,"median":-8.629782,"eighty":-5.815746,"marketCap":242291825},{"date":"2024-01-26","current":-4.927977,"twenty":-11.292577,"median":-8.600502,"eighty":-5.780023,"marketCap":238085369},{"date":"2024-02-02","current":-5.006337,"twenty":-11.199619,"median":-8.585761,"eighty":-5.716494,"marketCap":241871179},{"date":"2024-02-09","current":-4.562297,"twenty":-11.157999,"median":-8.553331,"eighty":-5.660612,"marketCap":220418257},{"date":"2024-02-16","current":-4.840911,"twenty":-11.109501,"median":-8.520481,"eighty":-5.582206,"marketCap":233878914},{"date":"2024-02-23","current":-4.44911,"twenty":-11.107206,"median":-8.503948,"eighty":-5.531389,"marketCap":214949865},{"date":"2024-03-01","current":-3.308907,"twenty":-11.065253,"median":-8.450504,"eighty":-5.425178,"marketCap":221680194},{"date":"2024-03-08","current":-3.077158,"twenty":-11.026791,"median":-8.406267,"eighty":-5.308737,"marketCap":206154167},{"date":"2024-03-15","current":-3.102484,"twenty":-11.012924,"median":-8.370716,"eighty":-5.206723,"marketCap":207850909},{"date":"2024-03-22","current":-3.197458,"twenty":-10.980747,"median":-8.337022,"eighty":-5.168824,"marketCap":214213692},{"date":"2024-03-28","current":-3.577354,"twenty":-10.949764,"median":-8.293845,"eighty":-5.133489,"marketCap":239664824},{"date":"2024-04-05","current":-4.064887,"twenty":-10.882731,"median":-8.255691,"eighty":-5.042905,"marketCap":272327110},{"date":"2024-04-12","current":-4.476441,"twenty":-10.811536,"median":-8.192932,"eighty":-4.983583,"marketCap":299899169},{"date":"2024-04-19","current":-4.368958,"twenty":-10.781343,"median":-8.156467,"eighty":-4.929718,"marketCap":292698365},{"date":"2024-04-26","current":-4.210663,"twenty":-10.745711,"median":-8.101591,"eighty":-4.905516,"marketCap":282093352},{"date":"2024-05-03","current":-4.280313,"twenty":-10.672045,"median":-8.073894,"eighty":-4.840911,"marketCap":286759558},{"date":"2024-05-10","current":-4.96415,"twenty":-10.664627,"median":-8.044877,"eighty":-4.817379,"marketCap":332573215},{"date":"2024-05-17","current":-4.807504,"twenty":-10.664627,"median":-8.011574,"eighty":-4.801428,"marketCap":388143484},{"date":"2024-05-24","current":-4.387176,"twenty":-10.664627,"median":-7.970027,"eighty":-4.742525,"marketCap":354207442},{"date":"2024-05-31","current":-4.376668,"twenty":-10.664627,"median":-7.943413,"eighty":-4.651329,"marketCap":353359041},{"date":"2024-06-07","current":-4.613103,"twenty":-10.664627,"median":-7.943413,"eighty":-4.601414,"marketCap":372448065},{"date":"2024-06-14","current":-4.497512,"twenty":-10.664874,"median":-7.900245,"eighty":-4.564052,"marketCap":363115653},{"date":"2024-06-21","current":-3.788208,"twenty":-10.665121,"median":-7.849613,"eighty":-4.534314,"marketCap":305848582},{"date":"2024-06-28","current":-3.793463,"twenty":-10.66865,"median":-7.826644,"eighty":-4.519134,"marketCap":306272782},{"date":"2024-07-05","current":-3.940577,"twenty":-10.650054,"median":-7.808919,"eighty":-4.508021,"marketCap":318150397},{"date":"2024-07-12","current":-4.45548,"twenty":-10.602867,"median":-7.747352,"eighty":-4.497512,"marketCap":359722049},{"date":"2024-07-15","current":-4.476496,"twenty":-10.596755,"median":-7.7222,"eighty":-4.497512,"marketCap":361418851},{"date":"2024-08-02","current":-3.325847,"twenty":-10.578207,"median":-7.559041,"eighty":-4.474894,"marketCap":268518935},{"date":"2024-08-09","current":-2.700609,"twenty":-10.578207,"median":-7.511408,"eighty":-4.445712,"marketCap":218039072},{"date":"2024-08-16","current":-1.428289,"twenty":-10.578207,"median":-7.48442,"eighty":-4.417713,"marketCap":124165489},{"date":"2024-08-23","current":-1.369391,"twenty":-10.578207,"median":-7.414715,"eighty":-4.368398,"marketCap":119045262},{"date":"2024-08-30","current":-1.197604,"twenty":-10.578207,"median":-7.31913,"eighty":-4.342793,"marketCap":104111269},{"date":"2024-09-06","current":-1.020908,"twenty":-10.578207,"median":-7.268599,"eighty":-4.299308,"marketCap":88750590},{"date":"2024-09-13","current":-0.952193,"twenty":-10.57053,"median":-7.199796,"eighty":-4.265299,"marketCap":82776992},{"date":"2024-09-20","current":-0.952193,"twenty":-10.552805,"median":-7.163976,"eighty":-4.203283,"marketCap":82776992},{"date":"2024-09-27","current":-0.824579,"twenty":-10.525337,"median":-7.123217,"eighty":-4.090084,"marketCap":71683169},{"date":"2024-10-04","current":-0.711691,"twenty":-10.4973,"median":-7.056517,"eighty":-4.042507,"marketCap":61869401},{"date":"2024-10-11","current":-0.633159,"twenty":-10.414401,"median":-7.005278,"eighty":-3.999567,"marketCap":55042433},{"date":"2024-10-18","current":-0.716599,"twenty":-10.343336,"median":-6.99446,"eighty":-3.935721,"marketCap":62296087},{"date":"2024-10-25","current":-0.736232,"twenty":-10.290696,"median":-6.962367,"eighty":-3.916296,"marketCap":64002829},{"date":"2024-10-31","current":-0.785314,"twenty":-10.224124,"median":-6.939632,"eighty":-3.906623,"marketCap":68269684},{"date":"2024-11-08","current":-0.377883,"twenty":-10.16594,"median":-6.892343,"eighty":-3.872942,"marketCap":32116639},{"date":"2024-11-15","current":-0.463192,"twenty":-10.108795,"median":-6.877417,"eighty":-3.82734,"marketCap":39367166},{"date":"2024-11-22","current":-0.531171,"twenty":-10.076692,"median":-6.861307,"eighty":-3.788291,"marketCap":45144787},{"date":"2024-11-29","current":-1.363944,"twenty":-10.008707,"median":-6.82911,"eighty":-3.748307,"marketCap":115922995},{"date":"2024-12-06","current":-1.129516,"twenty":-9.958444,"median":-6.798296,"eighty":-3.687233,"marketCap":95998730},{"date":"2024-12-13","current":-0.855236,"twenty":-9.882798,"median":-6.779649,"eighty":-3.610752,"marketCap":72687340},{"date":"2024-12-20","current":-0.720653,"twenty":-9.865302,"median":-6.743758,"eighty":-3.581084,"marketCap":61249001},{"date":"2024-12-27","current":-0.691243,"twenty":-9.849284,"median":-6.732995,"eighty":-3.514038,"marketCap":58749411},{"date":"2025-01-03","current":-0.748678,"twenty":-9.806688,"median":-6.710314,"eighty":-3.484906,"marketCap":63630856},{"date":"2025-01-10","current":-0.745587,"twenty":-9.766379,"median":-6.668233,"eighty":-3.443141,"marketCap":63368218},{"date":"2025-01-17","current":-0.682185,"twenty":-9.757593,"median":-6.64746,"eighty":-3.394029,"marketCap":57979610},{"date":"2025-01-24","current":-0.777875,"twenty":-9.728647,"median":-6.634163,"eighty":-3.357836,"marketCap":66112333},{"date":"2025-01-31","current":-0.764235,"twenty":-9.679607,"median":-6.615947,"eighty":-3.33003,"marketCap":64953103},{"date":"2025-02-07","current":-0.728538,"twenty":-9.627716,"median":-6.602833,"eighty":-3.302322,"marketCap":61919181},{"date":"2025-02-14","current":-0.694653,"twenty":-9.575681,"median":-6.587368,"eighty":-3.285899,"marketCap":59039219},{"date":"2025-02-21","current":-0.790555,"twenty":-9.547301,"median":-6.571503,"eighty":-3.269086,"marketCap":67190054},{"date":"2025-02-28","current":-0.6288,"twenty":-9.504726,"median":-6.5445,"eighty":-3.25033,"marketCap":53442312},{"date":"2025-03-07","current":-0.659169,"twenty":-9.471913,"median":-6.535863,"eighty":-3.205797,"marketCap":56023410},{"date":"2025-03-14","current":-0.708434,"twenty":-9.46119,"median":-6.523067,"eighty":-3.172132,"marketCap":54251153},{"date":"2025-03-21","current":-0.730966,"twenty":-9.46119,"median":-6.505302,"eighty":-3.135359,"marketCap":55976617},{"date":"2025-03-28","current":-0.524344,"twenty":-9.45159,"median":-6.471711,"eighty":-3.095717,"marketCap":40153746},{"date":"2025-04-04","current":-0.50337,"twenty":-9.439312,"median":-6.424459,"eighty":-3.068441,"marketCap":38547597},{"date":"2025-04-11","current":-0.530456,"twenty":-9.431377,"median":-6.38555,"eighty":-3.053997,"marketCap":40621824},{"date":"2025-04-17","current":-0.574322,"twenty":-9.419093,"median":-6.347165,"eighty":-3.027788,"marketCap":43980972},{"date":"2025-04-25","current":-0.559101,"twenty":-9.384913,"median":-6.325743,"eighty":-2.990813,"marketCap":42815366},{"date":"2025-05-02","current":-0.567835,"twenty":-9.330001,"median":-6.290473,"eighty":-2.93622,"marketCap":43484231},{"date":"2025-05-09","current":-0.501308,"twenty":-9.305504,"median":-6.248269,"eighty":-2.852042,"marketCap":38389651},{"date":"2025-05-16","current":-0.899541,"twenty":-9.281378,"median":-6.196397,"eighty":-2.778275,"marketCap":59360719},{"date":"2025-05-23","current":-0.868986,"twenty":-9.266302,"median":-6.118024,"eighty":-2.732134,"marketCap":57344415},{"date":"2025-05-30","current":-0.763727,"twenty":-9.233944,"median":-6.06626,"eighty":-2.68702,"marketCap":50398342},{"date":"2025-06-06","current":-0.817828,"twenty":-9.165249,"median":-6.028618,"eighty":-2.612139,"marketCap":53968494},{"date":"2025-06-13","current":-0.944392,"twenty":-9.144284,"median":-5.995401,"eighty":-2.518608,"marketCap":62320431},{"date":"2025-06-20","current":-0.811241,"twenty":-9.06243,"median":-5.977628,"eighty":-2.425137,"marketCap":53533786},{"date":"2025-06-27","current":-0.816427,"twenty":-8.99924,"median":-5.954094,"eighty":-2.405095,"marketCap":53876003},{"date":"2025-07-03","current":-0.990504,"twenty":-8.97729,"median":-5.94435,"eighty":-2.294861,"marketCap":65363384},{"date":"2025-07-11","current":-1.222888,"twenty":-8.960121,"median":-5.929245,"eighty":-1.478825,"marketCap":80698391},{"date":"2025-07-18","current":-1.198641,"twenty":-8.960121,"median":-5.887193,"eighty":-1.452831,"marketCap":79098297},{"date":"2025-07-24","current":-0.987841,"twenty":-8.960121,"median":-5.850885,"eighty":-1.407789,"marketCap":65187651},{"date":"2025-08-01","current":-0.789096,"twenty":-8.963555,"median":-5.80983,"eighty":-1.382153,"marketCap":52072427},{"date":"2025-08-08","current":-0.856372,"twenty":-8.963555,"median":-5.794312,"eighty":-1.363672,"marketCap":56511994},{"date":"2025-08-15","current":-1.195298,"twenty":-8.963555,"median":-5.794312,"eighty":-1.34192,"marketCap":58091473},{"date":"2025-08-22","current":-1.115611,"twenty":-8.963555,"median":-5.724733,"eighty":-1.266932,"marketCap":54218708},{"date":"2025-08-29","current":-1.078683,"twenty":-8.963555,"median":-5.677369,"eighty":-1.252587,"marketCap":52424012},{"date":"2025-09-05","current":-1.002884,"twenty":-8.966989,"median":-5.644274,"eighty":-1.207787,"marketCap":48740162},{"date":"2025-09-12","current":-0.960125,"twenty":-8.963555,"median":-5.551394,"eighty":-1.192797,"marketCap":46662093},{"date":"2025-09-19","current":-0.785204,"twenty":-8.963555,"median":-5.43708,"eighty":-1.164025,"marketCap":38160902},{"date":"2025-09-26","current":-0.794922,"twenty":-8.963555,"median":-5.315424,"eighty":-1.147146,"marketCap":38633191},{"date":"2025-10-03","current":-0.882382,"twenty":-8.963555,"median":-5.196764,"eighty":-1.129391,"marketCap":42883786},{"date":"2025-10-10","current":-0.835737,"twenty":-8.963555,"median":-5.149792,"eighty":-1.086069,"marketCap":40616802},{"date":"2025-10-17","current":-0.822132,"twenty":-8.963555,"median":-5.045518,"eighty":-1.068425,"marketCap":39955598},{"date":"2025-10-24","current":-0.767712,"twenty":-8.963555,"median":-5.001691,"eighty":-1.020024,"marketCap":37310783},{"date":"2025-10-31","current":-0.686082,"twenty":-8.963555,"median":-4.951178,"eighty":-0.991856,"marketCap":33343561},{"date":"2025-11-07","current":-0.695799,"twenty":-8.963555,"median":-4.919271,"eighty":-0.979561,"marketCap":33815849},{"date":"2025-11-14","current":-0.752163,"twenty":-8.963555,"median":-4.842662,"eighty":-0.956119,"marketCap":36555122},{"date":"2025-11-21","current":-1.466516,"twenty":-8.963555,"median":-4.817569,"eighty":-0.95209,"marketCap":38149940},{"date":"2025-11-28","current":-3.319725,"twenty":-8.963555,"median":-4.80244,"eighty":-0.95209,"marketCap":86359318}],"updateTime":1764443215160},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VRCA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2577893150","title":"BUZZ-Verrica Pharma climbs after EU nod clears path for skin drug filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2577893150","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577893150?lang=en_us&edition=fundamental","pubTime":"2025-10-21 04:24","pubTimestamp":1760991896,"startTime":"0","endTime":"0","summary":"BUZZ-Verrica Pharma climbs after EU nod clears path for skin drug filing** Shares of drug developer Verrica Pharmaceuticals VRCA.O rise 17% to $5.17 in extended trading** Co says it received positive feedback from the European Medicines Agency for its skin disease treatment, Ycanth** Co plans to submit a regulatory filing for the drug in the European Union as early as the fourth quarter of 2026** The drug, already approved in the U.S. and Japan to treat molluscum contagiosum, a common viral skin infection that spreads through direct contact and mostly affects children** Stock down 36% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nL4N3W10VG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2577742898","title":"Verrica Pharmaceuticals Inc - Plans Regulatory Submission for Ycanth by Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2577742898","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577742898?lang=en_us&edition=fundamental","pubTime":"2025-10-21 04:05","pubTimestamp":1760990700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nTUA509VPF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2577201898","title":"Verrica Pharmaceuticals Receives Positive Feedback From the European Medicines Agency (Ema) Supporting a Clear Regulatory Path Forward to File for Approval of Ycanth® in the European Union","url":"https://stock-news.laohu8.com/highlight/detail?id=2577201898","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577201898?lang=en_us&edition=fundamental","pubTime":"2025-10-21 04:05","pubTimestamp":1760990700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nTUA509VPF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2573936569","title":"Verrica Pharmaceuticals Announces Positive Phase 2 Trial Results for VP-315 in Basal Cell Carcinoma at SITC 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2573936569","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573936569?lang=en_us&edition=fundamental","pubTime":"2025-10-08 04:05","pubTimestamp":1759867517,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Announces Positive Phase 2 Trial Results for VP-315 in Basal Cell Carcinoma at SITC 2025 Annual Meeting. Verrica Pharmaceuticals Inc. has announced that new data from its Phase 2 clinical trial of VP-315, an investigational oncolytic peptide for the treatment of basal cell carcinoma , will be presented at the 40th Annual Meeting of the Society for Immunotherapy of Cancer . The company will deliver both an oral presentation and a poster on the exploratory analysis of local immune activation in the tumor microenvironment 12 weeks after VP-315 treatment. The presentations are scheduled for November 5-9, 2025, at the Gaylord National Resort and Convention Center in National Harbor, Maryland. The abstract is expected to be available on the SITC website on or about November 4, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nNDL4K3frW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007","IE00BGHQF748.EUR","LU2095319765.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU0314104364.USD","LU2210149790.SGD","BK4585","BK4588","LU2210150020.SGD","NDAQ","BK4112"],"gpt_icon":0},{"id":"2568926350","title":"Verrica Says Development Partner Receives Japanese Approval For Ycanth; Shares Rise Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2568926350","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568926350?lang=en_us&edition=fundamental","pubTime":"2025-09-19 20:35","pubTimestamp":1758285308,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals  said Friday that its development partner, Torii Pharmaceutical, has received approval from the Japanese Ministry of Health, Labour and Welfare for Ycanth, a drug-device combination product for the treatment of molluscum contagiosum.The approval of Ycanth in Japan triggered a one-time $10 million milestone cash payment which Verrica Pharmaceuticals said it expects to receive in coming weeks.Looking ahead, the dermatology therapeutics company said it expects to begin patient dosing in the US by the end of 2025 for its global phase 3 trial to study Ycanth for the treatment of common warts.Shares of Verrica Pharmaceuticals were up 14% in recent Friday premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2568426836","title":"Verrica Pharmaceuticals Inc - Approval Triggers $10 Mln Milestone Payment to Verrica","url":"https://stock-news.laohu8.com/highlight/detail?id=2568426836","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568426836?lang=en_us&edition=fundamental","pubTime":"2025-09-19 20:00","pubTimestamp":1758283200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250919:nTUA3YBJNP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2568297250","title":"Verrica Pharmaceuticals Announces That Development Partner, Torii Pharmaceutical, Receives Approval for Ycanth® (to-208) in Japan for the Treatment of Molluscum Contagiosum","url":"https://stock-news.laohu8.com/highlight/detail?id=2568297250","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568297250?lang=en_us&edition=fundamental","pubTime":"2025-09-19 20:00","pubTimestamp":1758283200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250919:nTUA3YBJNP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2564809385","title":"Verrica Pharmaceuticals Inc. to Present at H.C. Wainwright 27th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2564809385","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564809385?lang=en_us&edition=fundamental","pubTime":"2025-09-02 19:00","pubTimestamp":1756810824,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc., a dermatology therapeutics company, announced that its President and CEO, Jayson Rieger, will present at the H.C. Wainwright 27th Annual Global Investment Conference. The event is scheduled to take place in New York City on September 8, 2025, at 9:30 am ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verrica Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on September 02, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDL8kDMP0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","VRCA","NDAQ","BK4112","IE00BKPKM429.USD","BK4585","LU0314104364.USD","IE00B64PRP62.GBP","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4007","LU2210149790.SGD","BK4588","LU2095319765.USD"],"gpt_icon":0},{"id":"2562470435","title":"Lytix Biopharma AS Announces Milestone-Rich Second Half of 2025 with Advancements in Ruxotemitide Clinical Trials and Strategic Preparations for Future Commercialization","url":"https://stock-news.laohu8.com/highlight/detail?id=2562470435","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562470435?lang=en_us&edition=fundamental","pubTime":"2025-08-28 13:07","pubTimestamp":1756357637,"startTime":"0","endTime":"0","summary":"Lytix Biopharma AS Announces Milestone-Rich Second Half of 2025 with Advancements in Ruxotemitide Clinical Trials and Strategic Preparations for Future Commercialization. Lytix Biopharma AS, a clinical-stage immuno-oncology company, has announced advancements in its clinical programs, positioning the company for a milestone-rich second half of 2025. The company is making strides in the development of Ruxotemitide , with the program reaching significant milestones. A successful End-of-Phase II FDA meeting for basal cell carcinoma has been completed through its partner Verrica, and patient treatment in the ATLAS-IT-05 trial in advanced melanoma has concluded. Additionally, enrollment is ongoing in the NeoLIPA study for early-stage melanoma, with interim results anticipated in November 2025. The results for the second quarter and first half of 2025 were presented in a webcast by CEO ystein Rekdal and CFO Gjest Breistein, with a recording available on the company's website.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL9nX8lT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2559704866","title":"U.S. RESEARCH ROUNDUP-Apollo, Blackstone, Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2559704866","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559704866?lang=en_us&edition=fundamental","pubTime":"2025-08-13 16:25","pubTimestamp":1755073514,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Apollo, Blackstone, NvidiaAug 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apollo, Blackston","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nL4N3U50HI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORLY","NVDS","WMT","CG","APO","VRCA","LQDA","IIIV","CE","NVDD","LITE","SAIL","NVDU","NVD","INSM","NVDY","ACHC","CNNE","AHR","01698","ARES","LOW","NVDX","NVDA","OKE","2NVD.UK","PSN","SNV","CAH","OGS","TPG","DNLI","EVEX","BX","DELL","BN","CAVA","ECL","TNET","GBIO","PNFP","KKR","BAM","CMP"],"gpt_icon":1},{"id":"2559672895","title":"Verrica Pharmaceuticals Inc : TD Cowen Raises Target Price to $20 From $5","url":"https://stock-news.laohu8.com/highlight/detail?id=2559672895","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559672895?lang=en_us&edition=fundamental","pubTime":"2025-08-13 14:50","pubTimestamp":1755067835,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nFWN3U50U9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2559159629","title":"Verrica Pharmaceuticals Q2 Adj. EPS $0.25 Beats $(0.07) Estimate, Sales $12.702M Beat $4.367M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559159629","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559159629?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:02","pubTimestamp":1755028959,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $(0.07) by 457.14 percent. This is a 180.65 percent increase over losses of $(0.31) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47073416/verrica-pharmaceuticals-q2-adj-eps-0-25-beats-0-07-estimate-sales-12-702m-beat-4-367m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Verrica Pharmaceuticals Q2 Adj. EPS $0.25 Beats $(0.07) Estimate, Sales $12.702M Beat $4.367M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA"],"gpt_icon":0},{"id":"2557573043","title":"Verrica Pharmaceuticals Inc  expected to post a loss of 70 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2557573043","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557573043?lang=en_us&edition=fundamental","pubTime":"2025-08-08 23:22","pubTimestamp":1754666571,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc  expected to post a loss of70cents a share - Earnings Preview Verrica Pharmaceuticals Inc VRCA.OQ VRCA.O is expected to  show a fall in quarterly revenue when it reports  r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250808:nL8N3U02Q7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA"],"gpt_icon":0},{"id":"2557637713","title":"BRIEF-Verrica Pharmaceuticals To Report Second Quarter 2025 Financial Results And Provide A Corporate Update On August 12, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2557637713","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557637713?lang=en_us&edition=fundamental","pubTime":"2025-08-06 21:16","pubTimestamp":1754486171,"startTime":"0","endTime":"0","summary":"BRIEF-Verrica Pharmaceuticals To Report Second Quarter 2025 Financial Results And Provide A Corporate Update On August 12, 2025Verrica Pharmaceuticals Inc VRCA.O:VERRICA PHARMACEUTICALS TO REPORT SECO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250806:nTUAMD5SM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2557334375","title":"Verrica Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide a Corporate Update on August 12, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2557334375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557334375?lang=en_us&edition=fundamental","pubTime":"2025-08-06 19:00","pubTimestamp":1754478002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250806:nTUAMD5SM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2553102962","title":"Verrica Pharmaceuticals Announces 1-for-10 Reverse Stock Split Effective July 24, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2553102962","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553102962?lang=en_us&edition=fundamental","pubTime":"2025-07-23 20:01","pubTimestamp":1753272101,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. has announced a reverse stock split, converting every 10 shares of its common stock into one share. This change, effective July 24, 2025, aims to consolidate the company's share structure. As a result, the number of outstanding shares will drop from approximately 92.5 million to 9.25 million. The stock will begin trading on a split-adjusted basis on The Nasdaq Global Market on July 25, 2025, with a new CUSIP number, 92511W207. No fractional shares will be issued; shareholders will receive cash for any fractional entitlements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verrica Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, An","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250723:nNDL3VKmk1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2550463139","title":"Verrica Pharmaceuticals Inc. Reports 32.8% Increase in YCANTH® Sales for Q2 2025 and Receives $8M Milestone Payment from Torii Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=2550463139","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550463139?lang=en_us&edition=fundamental","pubTime":"2025-07-09 19:00","pubTimestamp":1752058842,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. Reports 32.8% Increase in YCANTH Sales for Q2 2025 and Receives $8M Milestone Payment from Torii Pharmaceutical. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verrica Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on July 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nNDLbSJRYR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","VRCA"],"gpt_icon":0},{"id":"2548003039","title":"BRIEF-Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2548003039","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548003039?lang=en_us&edition=fundamental","pubTime":"2025-07-01 19:17","pubTimestamp":1751368663,"startTime":"0","endTime":"0","summary":"BRIEF-Verrica Pharmaceuticals - To Receive $8 Million Milestone Payment In July 2025July 1 (Reuters) - Verrica Pharmaceuticals Inc VRCA.O:VERRICA PHARMACEUTICALS ANNOUNCES AMENDMENT TO COLLABORATION A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nTUA6TVTCQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2548003590","title":"Verrica Pharmaceuticals Announces Launch of Global Phase 3 Trial for YCANTH® to Treat Common Warts, Anticipates Dosing First Patient in Late 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2548003590","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548003590?lang=en_us&edition=fundamental","pubTime":"2025-07-01 19:00","pubTimestamp":1751367650,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Announces Launch of Global Phase 3 Trial for YCANTH to Treat Common Warts, Anticipates Dosing First Patient in Late 2025. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verrica Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on July 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250701:nNDL9w0Pwd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B64PRP62.GBP","LU2095319765.USD","BK4588","NDAQ","LU2210149790.SGD","IE00BGHQF748.EUR","LU2210150020.SGD","BK4112","BK4007","IE00BKPKM429.USD","IE00B3QW5Z07.USD","VRCA"],"gpt_icon":0},{"id":"2543420055","title":"Verrica Pharmaceuticals Announces Sixth Amendment to Credit Agreement with Lenders","url":"https://stock-news.laohu8.com/highlight/detail?id=2543420055","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2543420055?lang=en_us&edition=fundamental","pubTime":"2025-06-13 04:28","pubTimestamp":1749760114,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. has announced the entry into the sixth amendment and waiver to its Credit Agreement originally dated July 26, 2023. This amendment, effective June 10, 2025, involves a collaboration with OrbiMed Royalty & Credit Opportunities IV, LP, acting as both lender and administrative agent. Under the terms of this amendment, the lenders have agreed to waive specific covenants, particularly the requirement for no \"going concern\" qualification in the company's financial statements for certain upcoming periods. In return, Verrica Pharmaceuticals has agreed to pay an amendment fee of $110,465.12. The terms of the original Credit Agreement remain largely unchanged except for the provisions detailed in the Sixth Amendment. The company plans to file this amendment as an exhibit in its upcoming quarterly report.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250612:nNDL68KD6z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":41,"code":"91000000","status":"200"}]}}